Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2015 (2015), Article ID 124630, 12 pages
http://dx.doi.org/10.1155/2015/124630
Research Article

Nonsynonymous Single-Nucleotide Variations on Some Posttranslational Modifications of Human Proteins and the Association with Diseases

1School of Life Science and Biotechnology, Shanghai Jiao Tong University, 800 Dong Chuan Road, Shanghai 200240, China
2Shanghai Center for Bioinformation Technology, Shanghai Academy of Science and Technology, 1278 Ke Yuan Road, Shanghai 201203, China

Received 25 March 2015; Accepted 12 May 2015

Academic Editor: Lin Lu

Copyright © 2015 Bo Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. G. Tooley and C. E. Schaner Tooley, “New roles for old modifications: emerging roles of N-terminal post-translational modifications in development and disease,” Protein Science, vol. 23, no. 12, pp. 1641–1649, 2014. View at Publisher · View at Google Scholar
  2. J. Seo and K.-J. Lee, “Post-translational modifications and their biological functions: proteomic analysis and systematic approaches,” Journal of Biochemistry and Molecular Biology, vol. 37, no. 1, pp. 35–44, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Haglund and I. Dikic, “Ubiquitylation and cell signaling,” The EMBO Journal, vol. 24, no. 19, pp. 3353–3359, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Nakayama, J. C. Rice, B. D. Strahl, C. D. Allis, and S. I. S. Grewal, “Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly,” Science, vol. 292, no. 5514, pp. 110–113, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. S. T. Sherry, M. Ward, and K. Sirotkin, “dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation,” Genome Research, vol. 9, no. 8, pp. 677–679, 1999. View at Google Scholar · View at Scopus
  6. K. Karagiannis, V. Simonyan, and R. Mazumder, “SNVDis: a proteome-wide analysis service for evaluating nsSNVs in protein functional sites and pathways,” Genomics, Proteomics and Bioinformatics, vol. 11, no. 2, pp. 122–126, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. M. J. Landrum, J. M. Lee, G. R. Riley et al., “ClinVar: public archive of relationships among sequence variation and human phenotype,” Nucleic Acids Research, vol. 42, no. 1, pp. D980–D985, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Bamford, E. Dawson, S. Forbes et al., “The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website,” British Journal of Cancer, vol. 91, no. 2, pp. 355–358, 2004. View at Google Scholar · View at Scopus
  9. A. Mottaz, F. P. A. David, A.-L. Veuthey, and Y. L. Yip, “Easy retrieval of single amino-acid polymorphisms and phenotype information using SwissVar,” Bioinformatics, vol. 26, no. 6, pp. 851–852, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Greenman, P. Stephens, R. Smith et al., “Patterns of somatic mutation in human cancer genomes,” Nature, vol. 446, no. 7132, pp. 153–158, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Cole, K. Krampis, K. Karagiannis et al., “Non-synonymous variations in cancer and their effects on the human proteome: workflow for NGS data biocuration and proteome-wide analysis of TCGA data,” BMC Bioinformatics, vol. 15, no. 1, article 28, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Radivojac, P. H. Baenziger, M. G. Kann, M. E. Mort, M. W. Hahn, and S. D. Mooney, “Gain and loss of phosphorylation sites in human cancer,” Bioinformatics, vol. 24, no. 16, pp. i241–i247, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Manié, A. Vincent-Salomon, J. Lehmann-Che et al., “High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors,” Cancer Research, vol. 69, no. 2, pp. 663–671, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Benzeno, F. Lu, M. Guo et al., “Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1,” Oncogene, vol. 25, no. 47, pp. 6291–6303, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Hunter, “The age of crosstalk: phosphorylation, ubiquitination, and beyond,” Molecular Cell, vol. 28, no. 5, pp. 730–738, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J.-S. Lee, E. Smith, and A. Shilatifard, “The language of histone crosstalk,” Cell, vol. 142, no. 5, pp. 682–685, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Li, J. Jia, H. Li et al., “SysPTM 2.0: an updated systematic resource for post-translational modification,” Database, vol. 2014, p. bau025, 2014. View at Publisher · View at Google Scholar
  18. C. T. Lu, K. Y. Huang, M. G. Su et al., “DbPTM 3.0: an informative resource for investigating substrate site specificity and functional association of protein post-translational modifications,” Nucleic Acids Research, vol. 41, no. 1, pp. D295–D305, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Magrane and U. P. Consortium, “UniProt Knowledgebase: a hub of integrated protein data,” Database, vol. 2011, Article ID bar009, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. I. A. Adzhubei, S. Schmidt, L. Peshkin et al., “A method and server for predicting damaging missense mutations,” Nature Methods, vol. 7, no. 4, pp. 248–249, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Reimand, O. Wagih, and G. D. Bader, “The mutational landscape of phosphorylation signaling in cancer,” Scientific Reports, vol. 3, article 2651, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. J. D. Graves and E. G. Krebs, “Protein phosphorylation and signal transduction,” Pharmacology and Therapeutics, vol. 82, no. 2-3, pp. 111–121, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Beltrao, P. Bork, N. J. Krogan, and V. van Noort, “Evolution and functional cross-talk of protein post-translational modifications,” Molecular Systems Biology, vol. 9, article 714, 2013. View at Publisher · View at Google Scholar
  24. M. M. Chen, A. I. Bartlett, P. S. Nerenberg et al., “Perturbing the folding energy landscape of the bacterial immunity protein Im7 by site-specific N-linked glycosylation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 52, pp. 22528–22533, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Verdone, E. Agricola, M. Caserta, and E. di Mauro, “Histone acetylation in gene regulation,” Briefings in Functional Genomics & Proteomics, vol. 5, no. 3, pp. 209–221, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Amberger, C. Bocchini, and A. Hamosh, “A new face and new challenges for Online Mendelian Inheritance in Man (OMIM),” Human Mutation, vol. 32, no. 5, pp. 564–567, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. X. Jiao, B. T. Sherman, D. W. Huang et al., “DAVID-WS: a stateful web service to facilitate gene/protein list analysis,” Bioinformatics, vol. 28, no. 13, pp. 1805–1806, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Duan and D. Walther, “The roles of post-translational modifications in the context of protein interaction networks,” PLoS Computational Biology, vol. 11, no. 2, Article ID e1004049, 2015. View at Publisher · View at Google Scholar
  29. P. Minguez, I. Letunic, L. Parca, and P. Bork, “PTMcode: a database of known and predicted functional associations between post-translational modifications in proteins,” Nucleic Acids Research, vol. 41, no. 1, pp. D306–D311, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Szklarczyk, A. Franceschini, S. Wyder et al., “STRING v10: protein-protein interaction networks, integrated over the tree of life,” Nucleic Acids Research, vol. 43, pp. D447–D452, 2015. View at Publisher · View at Google Scholar
  31. The Cancer Genome Atlas Research Network, J. N. Weinstein, E. A. Collisson et al., “The Cancer Genome Atlas Pan-Cancer analysis project,” Nature Genetics, vol. 45, no. 10, pp. 1113–1120, 2013. View at Google Scholar
  32. P. Radivojac, P. H. Baenziger, M. G. Kann, M. E. Mort, M. W. Hahn, and S. D. Mooney, “Gain and loss of phosphorylation sites in human cancer,” Bioinformatics, vol. 24, no. 16, pp. I241–I247, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. G. A. Khoury, R. C. Baliban, and C. A. Floudas, “Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot database,” Scientific Reports, vol. 1, article 90, 2011. View at Publisher · View at Google Scholar
  34. P. Chen, L.-J. Xie, G.-Y. Huang, X.-Q. Zhao, and C. Chang, “Mutations of connexin43 in fetuses with congenital heart malformations,” Chinese Medical Journal, vol. 118, no. 12, pp. 971–976, 2005. View at Google Scholar · View at Scopus
  35. G. Richard, T. W. White, L. E. Smith et al., “Functional defects of Cx26 resulting from a heterozygous missense mutation in a family with dominant deaf-mutism and palmoplantar keratoderma,” Human Genetics, vol. 103, no. 4, pp. 393–399, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Campion, C. Dumanchin, D. Hannequin et al., “Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum,” The American Journal of Human Genetics, vol. 65, no. 3, pp. 664–670, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Dix, P. Robbins, S. Carrello, A. House, and B. Iacopetta, “Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas,” British Journal of Cancer, vol. 70, no. 4, pp. 585–590, 1994. View at Publisher · View at Google Scholar · View at Scopus
  38. The Cancer Genome Atlas Network, “Comprehensive molecular characterization of human colon and rectal cancer,” Nature, vol. 487, no. 7407, pp. 330–337, 2012. View at Publisher · View at Google Scholar
  39. M. F. Lavin and N. Gueven, “The complexity of p53 stabilization and activation,” Cell Death and Differentiation, vol. 13, no. 6, pp. 941–950, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. M. van Slegtenhorst, R. de Hoogt, C. Hermans et al., “Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34,” Science, vol. 277, no. 5327, pp. 805–808, 1997. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Sarkozy, E. Conti, D. Seripa et al., “Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes,” Journal of Medical Genetics, vol. 40, no. 9, pp. 704–708, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. B. Keren, A. Hadchouel, S. Saba et al., “PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience,” Journal of medical genetics, vol. 41, no. 11, article e117, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Tartaglia, K. Kalidas, A. Shaw et al., “PTPN11 mutations in noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity,” The American Journal of Human Genetics, vol. 70, no. 6, pp. 1555–1563, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Rutherford, C. E. Chu, P. M. Duddy et al., “Investigations on a clinically and functionally unusual and novel germline p53 mutation,” British Journal of Cancer, vol. 86, no. 10, pp. 1592–1596, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Sjöblom, S. Jones, L. D. Wood et al., “The consensus coding sequences of human breast and colorectal cancers,” Science, vol. 314, no. 5797, pp. 268–274, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. E. Arbustini, A. Pilotto, A. Repetto et al., “Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease,” Journal of the American College of Cardiology, vol. 39, no. 6, pp. 981–990, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. J. V. Olsen, B. Blagoev, F. Gnad et al., “Global, in vivo, and site-specific phosphorylation dynamics in signaling networks,” Cell, vol. 127, no. 3, pp. 635–648, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. N. Rifai, M. A. Gillette, and S. A. Carr, “Protein biomarker discovery and validation: the long and uncertain path to clinical utility,” Nature Biotechnology, vol. 24, no. 8, pp. 971–983, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Zhang, M. J. Guy, H. S. Norman et al., “Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure,” Journal of Proteome Research, vol. 10, no. 9, pp. 4054–4065, 2011. View at Publisher · View at Google Scholar · View at Scopus